Affordable Access

CCNU, etoposide, and prednimustine (CEP) in refractory Hodgkin's disease.

Authors
Type
Published Article
Journal
Seminars in Oncology
0093-7754
Publisher
Elsevier - WB Saunders
Publication Date
Volume
13
Issue
1 Suppl 1
Pages
23–26
Identifiers
PMID: 2420012
Source
Medline

Abstract

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments